<DOC>
	<DOCNO>NCT02609854</DOCNO>
	<brief_summary>ZetrOZ 's Ultrasonic Diathermy device intend use portable wearable medical device , apply various area body applies Low Intensity Therapeutic Ultrasound ( LITUS ) deep tissue . This device FDA-cleared pain reduction , treatment muscle spasm joint contracture , increase local circulation . This study look use therapeutic ultrasound relieve pain reduce disability subject chronic low back pain , subset chronic low back pain due herniated disc , 8-week treatment period .</brief_summary>
	<brief_title>Sustained Acoustic Medicine Chronic Low Back Pain Secondary Herniated Nucleus Pulposus Other Conditions</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<criteria>Diagnosis Chronic low back pain , may secondary herniated nucleus pulposus ( HNP ) cause 1860 year age , inclusive Has Numeric Rating Scale ( NRS ) pain severity score least 4 minimum 5 day 1 week Baseline Period prior randomize treatment Pain lasting &gt; 3 month Has MRI within 2 month prior Screening ( If recent MRI available , subject must agree MRI perform prior randomization treatment ) If pain secondary HNP : MRI within last 2 month demonstrate presence herniated disc ; herniated disc laterally locate centrally locate ; herniated disc sequester Has presence radicular pain assess health care practitioner Is willing able selfadminister treatment daily within place residence normal daily activity , exclude bathing , shower , water activity may result submersion study device . Is maintain stable pain management regimen , may include opioid and/or nonopioid analgesic medication , must willing keep dosage ( ) stable study period ; dose adjustment investigator feel require study period must discuss study sponsor ; use medication must document subject 's Medication Log . Be willing discontinue interventional treatment modality low back study period ( e.g. , transcutaneous electrical nerve stimulation , electronic muscle stimulation , traditional ultrasound ) . Can successfully demonstrate ability put take device . Displays condition , judgment investigator , would make participation study unacceptable include , limited , subject 's ability understand follow instruction . Participated clinical trial investigational drug and/or agent within 30 day prior screen . Has arthritis , bone spur , stenosis , fusion , implant near treatment area . Is pregnant . Is prisoner . Is nonambulatory ( unable walk ) . Has pacemaker . Has malignancy treatment area . Has active infection , open sore , wound treatment area . Has impair sensation treatment area , cause chemotherapy anesthesia . Has know neuropathy ( disease brain spinal nerve ) . Has hereditary disposition ( tendency ) excessive bleeding ( hemorrhage ) . Has peripheral artery disease . Has BMI â‰¥30</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>herniated disc</keyword>
	<keyword>sustain acoustic medicine</keyword>
	<keyword>ultrasound</keyword>
	<keyword>CLBP</keyword>
</DOC>